Recombinant Human Active PLK1 Protein, CF

Catalog # Availability Size / Price Qty
3804-KS-010
Recombinant Human Active PLK1 Protein SDS-PAGE
1 Image
Product Details
Citations (3)
FAQs
Reviews

Recombinant Human Active PLK1 Protein, CF Summary

Product Specifications

Purity
>90%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.
Activity
The specific activity of PLK1 was equivalent to 42 nmol/min/mg as per Activity Assay Protocol and was equivalent to 17 nmol/min/mg as per radiometric assay.
Source
Spodoptera frugiperda, Sf 9 (baculovirus)-derived human PLK1 protein
Accession #
N-terminal Sequence
Analysis
Using an N-terminal His tag
SDS-PAGE
70 kDa

Product Datasheets

You must select a language.

x

3804-KS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

3804-KS

Formulation Supplied in 50 mM Sodium Phosphate (pH 7.0), 300 mM NaCl, 150 mM Imidazole, 0.1 mM PMSF, 0.25 mM DTT, and 25% Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: This product is stable at ≤ ‑70 °C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.

Assay Procedure

Materials
  • Active Kinase - Active PLK1 (0.1 μg/μL) diluted with Kinase Dilution Buffer IX and assayed as outlined in Sample Activity Plot. Note: These are suggested working dilutions and it is recommended that the researcher perform a serial dilution of active PLK1 for optimal results.
  • Kinase Assay Buffer III (5X) - 200 mM Tris-HCl, pH 7.4, 100 mM MgCl2, and 0.5 mg/mL BSA. Add fresh DTT prior to use to a final concentration of 250 μM.
  • Kinase Dilution Buffer IX (1X) - Kinase Assay Buffer III diluted at a 1:4 ratio (5X dilution) with cold distilled or deionized water. Add fresh DTT to the aliquot prior to use to a final concentration of 50 μM.
  • ADP-Glo™ Kinase Assay Kit - 10 mM ATP Solution, 10 mM ADP Solution, ADP-Glo™ Reagent, and Kinase Detection Reagent.
  • Substrate - PLKtide peptide substrate was diluted in 20 mM Tris-HCl, pH 7.5 solution to a final concentration of 1 mg/mL.
  1. Thaw the Active PLK1, Kinase Assay Buffer III (5X), and Substrate on ice. Prepare a 15 μL enzyme dilution at the desired concentration, with Kinase Dilution Buffer IX (1X), in a pre-chilled 96-well plate.
  2. Prepare a Substrate/ATP mixture as follows (25 μM example):
    a. 10 mM ATP Solution: 1 μL
    b. Kinase Assay Buffer III (5X): 79 μL
    c. Substrate at 1 mg/mL: 80 μL
  3. Transfer the following reaction components prepared in Step 2 to a 384-well opaque plate, bringing the reaction volume up to 5 μL:
    a. 3 μL of diluted Active PLK1
    b. 2 μL of Substrate/ATP mix as prepared in Step 2. This initiates the reaction.
  4. Set up the blank control as outlined in Step 2, excluding the addition of the kinase. Replace the kinase with an equal volume of Kinase Dilution Buffer IX (1X).
  5. Incubate at ambient temperature for 40 minutes.
  6. After the 40 minute incubation period, terminate the reaction and deplete the remaining ATP by adding 5 μL of ADP-Glo™ Reagent. Spin down and shake the 384-well plate. Then incubate the reaction mixture for another 40 minutes at ambient temperature.
  7. Add 10 μL of the Kinase Detection Reagent to the 384-well plate and incubate the reaction mixture for another 30 minutes at ambient temperature.
  8. Read the 384-well reaction plate using the Luminescence Module Protocol on a GloMax®-Multi Microplate Multimode Reader.
  9. Determine the corrected activity (RLU) by removing the blank control value (see Step 4) for each sample and calculate the kinase specific activity as outlined below.


    Calculation of Specific Activity of ADP (RLU/pmol)
    From ADP standard curve, determine RLU/pmol of ADP

    Kinase Specific Activity (SA) (pmol/min/μg or nmol/min/mg)
    Corrected RLU from reaction / [(SA of ADP in RLU/pmol) x (Reaction time in min) x (Enzyme amount in μg or mg)]

Scientific Data

SDS-PAGE Recombinant Human Active PLK1 Protein SDS-PAGE View Larger

The approximate molecular weight is 70 kDa and the purity is > 90%.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: PLK1

PLK1 is a member of the Polo-Like Kinase family that localizes to centrosomes or spindle pole bodies and undergoes dramatic subcellular relocation during the cell cycle. Deregulated activities of PLKs often result in abnormalities in centrosome duplication, maturation, and/or microtubule dynamics (1). PLKs also regulate the function of the Golgi complex. Deregulated expression of human PLK1 is strongly correlated with the development of many types of malignancies, and ectopic expression of PLK1 dominant negative protein leads to rapid cell death (2).

References
  1. Nigg, E.A. et al. (1996) Exp. Cell Res. 229:174.
  2. Dai, W. et al. (2003) Prog. Cell Cycle Res. 5:327.
Long Name
Polo-like Kinase 1
Entrez Gene IDs
5347 (Human); 18817 (Mouse); 25515 (Rat)
Alternate Names
cell cycle regulated protein kinase; EC 2.7.11; EC 2.7.11.21; PLK; PLK1; PLK-1; polo (Drosophia)-like kinase; polo like kinase; polo-like kinase 1polo-like kinase (Drosophila); Serine/threonine-protein kinase 13; serine/threonine-protein kinase PLK1; STPK13

Citations for Recombinant Human Active PLK1 Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

3 Citations: Showing 1 - 3
Filter your results:

Filter by:

  1. PLK1 phosphorylates RhoGDI1 and promotes cancer cell migration and invasion
    Authors: Lim, J;Hwang, YS;Yoon, HR;Yoo, J;Yoon, SR;Jung, H;Cho, HJ;Lee, HG;
    Cancer cell international
    Species: olive baboon
    Sample Types: Recombinant Protein
    Applications: Bioassay
  2. PLK1 Regulates MicroRNA Biogenesis through Drosha Phosphorylation
    Authors: Fletcher, CE;Taylor, MA;Bevan, CL;
    International journal of molecular sciences
    Species: Human
    Sample Types: Peptide
    Applications: Bioassay
  3. CIP2A modulates cell-cycle progression in human cancer cells by regulating the stability and activity of Plk1.
    Authors: Kim J, Kim E, Oh J, Park I, Hwang S
    Cancer Res, 2013-08-27;73(22):6667-78.
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human Active PLK1 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Active PLK1 Protein, CF and earn rewards!

Have you used Recombinant Human Active PLK1 Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review